Ashley Zehnder, Fauna Bio CEO

Lil­ly-part­nered Fau­na Bio plans $40M Se­ries A to get in­to heart fail­ure

MI­A­MI — Fau­na Bio, a biotech that mines da­ta on dis­ease re­sis­tance from squir­rels and oth­er an­i­mals to cre­ate new drugs, is look­ing at rais­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.